Aliaksei Pustavoitau

Medicine & Life Sciences

1. Liver Transplantation 100%
2. Hospital Medicine 32%
3. Critical Care 32%
4. Transplant Recipients 28%
5. Point-of-Care Systems 24%
6. Medicine 20%
7. Intensive Care Units 20%
8. Transplants 19%
9. Hepatitis B 17%
10. Anesthesiology 17%
11. Critical Illness 17%
12. Pediatrics 17%
13. Immunoglobulins 16%
14. Ultrasonography 16%
15. Anesthesiologists 15%
16. Blood Banks 15%
17. Coronavirus 15%
18. Credentialing 14%
19. Tissue Donors 14%
20. Sepsis 13%
21. Length of Stay 13%
22. Delirium 13%
23. Nucleosides 12%
24. End Stage Liver Disease 12%
25. Septic Shock 12%
26. Needles 11%
27. Recurrence 11%
28. N-hydroxysuccinimide S-acetylthioacetate 11%
29. Coronary Artery Bypass 11%
30. Heart Arrest 11%
31. Equipment and Supplies 10%
32. Blood Vessels 10%
33. Antiviral Agents 10%
34. Thoracentesis 10%
35. Paracentesis 9%
36. Nucleotides 9%
37. Hemodynamics 9%
38. Brain Diseases 9%
39. Hepatitis B Antibodies 9%
40. Transducers 9%
41. Spinal Puncture 9%
42. Hospitalists 8%
43. Frailty 8%
44. Pandemics 8%
45. Physiologic Monitoring 8%
46. recombinant FVIIa 8%
47. Mortality 8%
48. Alcoholic Hepatitis 8%
49. Deep Learning 8%
50. Brain Injuries 8%